A plain language explanation of what half life means and what a ~6 day half life implies in practice. This page is educational only.
Keep exploring this topic
Move from half-life context to measurement math, modeled levels, results timelines, and direct comparisons.
Retatrutide s half life in humans is commonly reported as ~6 days (~144 hours). That long half life is one reason it s often described as compatible with once weekly administration in research settings (not a recommendation).
Half life is a simple way to describe how long something tends to stay in the body under a simplified model.
This is a simplified model. Real biology can differ based on the person, the amount used, and how the body clears it.
A longer half life usually means levels drop more slowly day to day. That tends to make weekly schedules feasible in clinical research.
If some amount is still present when the next dose is taken, levels can accumulate until they reach a plateau.
Rule of thumb: steady state is often described as ~4 5 half lives. With a ~6 day half life, that s roughly ~24 30 days (about ~4 5 weeks).
Another common rule of thumb is that after ~5 half lives, only a small fraction remains (around ~3% under the simplified model). With a ~6 day half life, that s roughly ~30 days.
This table is illustrative and based on a simplified decay model.
Some modern peptide medicines are designed with structural changes that make them break down more slowly and/or leave the bloodstream more slowly. That s one common way longer half lives are achieved.